- Research works
- 11 ▼ 53% vs 2013–17
- Citations
- 3.1k 271.1 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 54% world 28%
Not ranked overall: Génome Québec is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which research topics does Génome Québec publish most on?
By volume in 2022–2025: Renal and related cancers, Renal cell carcinoma treatment, Cancer-related gene regulation and Muscle Physiology and Disorders.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Renal and related cancers Molecular Biology 0 works
- 2 Renal cell carcinoma treatment Pulmonary and Respiratory Medicine 0 works
- 3 Cancer-related gene regulation Molecular Biology 0 works
- 4 Muscle Physiology and Disorders Molecular Biology 0 works
- 5 CAR-T cell therapy research Oncology 0 works
- 6 Myeloproliferative Neoplasms: Diagnosis and Treatment Genetics 0 works
- 7 RNA Research and Splicing Molecular Biology 0 works
- 8 RNA regulation and disease Molecular Biology 0 works
- 9 Artificial Intelligence in Healthcare and Education Health Informatics 0 works
- 10 RNA modifications and cancer Molecular Biology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Génome Québec's research output changed?
Output in 2018–2022 was 53% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Québec
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.